پن کیا گیا ٹویٹ
Insider Monkey
41.9K posts

Insider Monkey
@insidermonkey
Finance website following hedge funds and insiders. Our monthly newsletter's stock picks beat the S&P 500 by 66 percentage points in 3.5 years. See the link:
New York شامل ہوئے Eylül 2010
1.7K فالونگ20.6K فالوورز

Goldman Sachs Lowers BofA Price Target to $57
Goldman Sachs reduced its price target for Bank of America $BAC from $67 to $57 on March 23, maintaining a Buy rating. Regulatory changes by US authorities, specifically regarding Basel III Endgame and the G-SIB buffer, are expected to positively impact large-cap banks, keeping risk-weighted assets stable while reducing CET1 capital requirements by about $50 billion, easing capital constraints.
Separately, Bank of America settled a civil lawsuit on March 16 tied to allegations of enabling Jeffrey Epstein's abuse. While claims suggested the bank ignored suspicious transactions linked to Epstein, Bank of America stated it only provided standard banking services without deeper involvement. The bank is a major global financial institution serving various consumer and corporate segments.
Current price: $48.75 | YTD: -12.9%
English

5 High Growth Restaurant Stocks for 2026
1. Dutch Bros Inc. $BROS Dutch Bros Inc. is favored for its growth potential with Stifel reiterating a Buy rating and a $75 price target on March 13, despite a 16% year-to-date decline. The company's strategic development aims for financial leverage, but market performance is impacted by competitors’ product launches.
Current price: $51.33 | YTD: -17.4%
2. Brinker International, Inc. $EAT Brinker International is viewed as a strong near-term investment, with its Chili’s brand driving success. JPMorgan raised its price target to $190 on March 16. Analysts see a stabilization in sales through new upgrades and a commitment to a stable remodel program.
Current price: $147.11 | YTD: -2.9%
3. Domino's Pizza, Inc. $DPZ Domino's Pizza targets a 32.49% upside with a median analyst price target of $489. Growth is driven by 3% US same-store sales and 8% operating income growth. UBS maintains a Buy rating and a $500 price target from February 24.
Current price: $362.53 | YTD: -14.8%
4. Shake Shack Inc. $SHAK Shake Shack plans significant expansion with 55-60 new locations and a strategic focus on a loyalty program. Wolfe Research rated it Outperform with a $118 price target on March 9, crediting its sales improvement strategies.
Current price: $89.50 | YTD: +7.2%
5. Restaurant Brands International Inc. $QSR Restaurant Brands has Truist Securities cautious optimism, reflecting a price target increase to $87 on March 2 and plans for expansion in China. It's set to return 4.6% of its market cap to shareholders by 2026.
Current price: $72.92 | YTD: +7.5%

English

Corning's AI Partnership Boosts Outlook $GLW
Corning Incorporated, operating in optical communications and specialty materials, is experiencing positive momentum due to strategic AI-driven partnerships and robust forward guidance. The company's Q1 2026 guidance anticipates a 15% sales growth and 26% EPS expansion, driven largely by its optical communications segment. A significant multi-year agreement with Meta Platforms valued at up to $6 billion enhances revenue visibility and supports capacity expansion efforts.
Currently trading above its 50-day moving average, Corning's stock has seen analyst price targets exceed $170, indicating confidence in sustained AI infrastructure spending. Corning benefits from ongoing share buybacks and dividend support, although automotive and solar segments show softer trends.
According to Insider Monkey's database, 85 hedge fund portfolios held $GLW by the end of Q4, marking an increase from the previous quarter.
Current price: $142.09 | YTD: +56.7%
English

AI Growth Offsets Alibaba's Income Decline
Alibaba Group Holding Limited $BABA reported robust revenue growth driven primarily by its AI and Cloud sectors. For the quarter ended December 31, 2025, the company's revenue increased by 2% year-over-year to $40.7 billion, with its Cloud Intelligence Group revenue surging 36% to $6.19 billion. Despite this growth, Alibaba faced a 67% decline in non-GAAP net income, totaling $2.38 billion or $1.01 per share. Alibaba plans to leverage its strong liquidity and cash generation to further invest in AI capabilities and cloud services, reinforcing its position in these sectors.
The company's diverse operations encompass commerce, cloud computing, digital payments, and logistics, similar to a blend of Amazon, eBay, PayPal, and Google.
Current price: $126.08 | YTD: -19.0%
English

From a recent article:
"With a strengthened cash position of $1.1 billion, significant debt reduction, and robust multi-launch customer agreements, Rocket Lab is well-positioned for both organic and inorganic growth. The combination of record launch cadence, expanding national security contracts, and the upcoming Neutron program provides a compelling bullish investment case, offering meaningful upside as the company scales its end-to-end space capabilities and further consolidates its leadership in small and medium-lift orbital launches."
insidermonkey.com/blog/is-rocket…
English

@insidermonkey I'd watch $RKLB closely—execution on that backlog will be key. Guidance is the real lever here.
English

5 Best Diagnostics and Research Stocks
Ranked based on Hedge Fund Interest
1. Danaher Corporation $DHR Danaher Corporation $DHR is a leading global innovator in life sciences and diagnostics with 125 hedge fund holders. On March 3, 2026, the company projected a 3%-6% revenue growth driven by bioprocessing, with a 100-basis-point margin expansion. It announced a $0.40 per share dividend, payable on April 24, 2026.
2. Thermo Fisher Scientific Inc. $TMO Thermo Fisher Scientific Inc. $TMO is a life sciences and clinical research company with 113 hedge fund holders. On March 2, 2026, it partnered with AIM ImmunoTech on a Phase 3 Ampligen trial for pancreatic cancer. It receives a consensus Buy rating with a 1-year upside of 40.71%.
3. Natera, Inc. $NTRA Natera, Inc. $NTRA, with 74 hedge fund holders, is a leader in cfDNA testing. On March 12, 2026, it launched the Zenith assay for rare genetic condition diagnosis. Morgan Stanley has an Overweight rating with a price target of $250.
4. Agilent Technologies, Inc. $A Agilent Technologies, Inc. $A, held by 71 hedge funds, is acquiring Biocare Medical for $950 million. This will bolster its pathology division. The acquisition is expected to be accretive to revenue and margins.
5. IQVIA Holdings Inc. $IQV IQVIA Holdings Inc. $IQV, noted for clinical research and health data, has 69 hedge fund holders. TD Cowen upgraded it to Buy with a $213 price target on March 9, 2026, due to potential resilience against AI-driven revenue headwinds.

English

Boeing Gets 777 FAA Approval
The Boeing Company $BA received approval from the US Federal Aviation Administration on March 18 to advance its 777-9 jet into the fourth phase of certification testing. The 777-9, part of the long-delayed 777X series, is crucial as Boeing has already incurred $15 billion in charges and is six years behind schedule. Once certified, this model will become the largest twin-engine jet, aiming to reduce fuel use and emissions by 20%. Boeing plans the first flight of a production 777X jet in April. The 777X series enhances Boeing's wide-body offerings alongside the 787 Dreamliner. Emirates has committed to acquiring 65 units of the 777-9, part of a $38 billion order, cementing the model's importance in future fleet compositions.
Current price: $198.41 | YTD: -12.9%
English


